Table 3.
Gene set enrichment analysis (GSEA) of genes differentially expressed in the acute phase only
| Themea | Gene set | Genes | % Acutely enriched | −log(Q)b | |
|---|---|---|---|---|---|
| AN (FC >1) | SD (FC <1) | ||||
| Immune system | Cell adhesion molecules | 25 | 32 | 68 | Infinite |
| Cell surface interactions at the vascular wall | 17 | 71 | 29 | 10.4 | |
| Hematopoietic cell lineage | 14 | 64 | 36 | 7.6 | |
| Hemostasis | 45 | 67 | 33 | Infinite | |
| Immune system | 51 | 76 | 24 | 10.2 | |
| Leukocyte trans-endothelial migration | 17 | 59 | 41 | 8.7 | |
| Platelet activation, signaling, and aggregation | 21 | 62 | 38 | 8.1 | |
| Neurons and axons | Axon guidance (Kegg gene set) | 17 | 12 | 88 | 8.1 |
| Axon guidance (Reactome gene set) | 29 | 17 | 83 | 12.8 | |
| Neuroactive ligand-receptor interaction | 23 | 22 | 78 | 7.6 | |
| Neuronal system | 32 | 16 | 84 | Infinite | |
| Transmission across chemical synapses | 24 | 17 | 83 | 11.5 | |
| GPCR signaling | Class A1 rhodopsin-like receptors | 24 | 46 | 54 | 7.3 |
| GPCR ligand binding | 32 | 41 | 59 | 9.9 | |
| GPCR signaling | 45 | 42 | 58 | 7.6 | |
| Cell transport | Solute carrier-mediated transmembrane transport | 28 | 36 | 64 | 12.4 |
| Transmembrane transport of small molecules | 44 | 32 | 68 | Infinite | |
| Transport of inorganic cations/anions and amino acids/oligopeptides | 19 | 32 | 68 | 12.4 | |
| Other | Cell cycle | 17 | 94 | 6 | 8.2 |
| Developmental biology | 32 | 22 | 78 | 10.2 | |
FC fold change (AN FKPM divided by SD FKPM), Q false discovery rate-adjusted P value
aThe 20 most highly enriched gene sets have been manually grouped for conceptual purposes
bThe value of −log(Q) is given for the GSEA Q value for each gene set